---
title: "Otezla (apremilast), all indications: Drug interactions questions"
description: "Drug interactions questions on Otezla (apremilast) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What drug interactions does Otezla have? Does Otezla interact with methotrexate or birth control pills? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/otezla/drug-interactions"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Otezla (apremilast), all indications: Drug interactions questions

Manufacturer: Amgen Inc.  
Prescribing information: [Otezla](https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf)  
Indication pages: [Plaque psoriasis](https://www.evicenter.com/medical-information/otezla--plaque-psoriasis)

## Drug interactions

<a id="otezla-drug-interactions"></a>

### What drug interactions does Otezla have?

> “Co-administration of strong cytochrome P450 enzyme inducer, rifampin, resulted in a reduction of 
> systemic exposure of apremilast, which may result in a loss of efficacy of OTEZLA/OTEZLA XR. 
> Therefore, the use of cytochrome P450 enzyme inducers (e.g., rifampin, phenobarbital, carbamazepine, 
> phenytoin) with OTEZLA/OTEZLA XR is not recommended [see Drug Interactions (7.1) and Clinical 
> Pharmacology (12.3)].”

Source: [OTEZLA: Prescribing information, page 8, captured 2026-11-13](https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf#page=8)

> “Co-administration of the CYP450 inducer 
> rifampin (600 mg once daily for 15 days) with a single oral dose of 30-mg apremilast resulted in 
> reduction of apremilast AUC and Cmax by 72% and 43%, respectively”

Source: [OTEZLA: Prescribing information, page 18, captured 2026-11-13](https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf#page=18)

<a id="otezla-methotrexate-birth-control"></a>

### Does Otezla interact with methotrexate or birth control pills?

> “Drug interaction trials were performed with apremilast and CYP3A4 substrates (oral contraceptive 
> containing ethinyl estradiol and norgestimate), CYP3A and P-gp inhibitor (ketoconazole), CYP450 
> inducer (rifampin) and frequently co-administered drug in this patient population (methotrexate).”

Source: [OTEZLA: Prescribing information, page 18, captured 2026-11-13](https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf#page=18)

> “No significant pharmacokinetic interactions were observed when 30-mg oral apremilast was administered 
> with either oral contraceptive, ketoconazole, or methotrexate.”

Source: [OTEZLA: Prescribing information, page 18, captured 2026-11-13](https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf#page=18)

## Related pages
- [Medical information: Otezla (apremilast): All indications](https://www.evicenter.com/medical-information/otezla)
- [Indication](https://www.evicenter.com/medical-information/otezla/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/otezla/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/otezla/safety)
- [Specific populations](https://www.evicenter.com/medical-information/otezla/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/otezla/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/otezla/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/otezla/access-and-coverage)
